News fedaiisf

AIISF Messina. ISF access to IRCCS Bonino Pulejo with "Green Pass"

Press release Section AIISF Messina.

With a note dated 27-10-2021, the Administrative Department together with the Health Department, in response to the communications sent by our lawyer on 27-09-2021, the IRCCS Bonino Pulejo informed us that the access of Scientific Representatives to the own structures will take place through the exhibition of the green pass, which will be verified by the personnel in charge of this until the state of emergency persists and outside the hospitalizations and outpatient clinics, in a suitable place identified for this purpose as already provided for by the internal regulation n. 1470 of 05- 12-2019.


The story.

In September the IRCCS Bonino Pulejo of Messina had issued extremely restrictive rules for the access and activity of the ISF due to the health emergency, strangely just as the ministry of health stated that Sicily was returning to the white zone "after the parameters relating to infections and hospitalizations on the island remained below the risk threshold for two weeks”.

The restrictive rules were taken with internal measures without any prior communication to the category of scientific representatives of the drug. This conduct appeared quite serious if one recalls that, following some meetings requested and obtained by the AIISF Section of Messina, in a collaborative atmosphere with the health managers, it was agreed that the ISFs would have easy access, with due caution, at the Hospital Structures of Taormina and the Bonino Pulejo Neurolesi Center.

To aggravate the situation, the health personnel gave the ISF "instructions" regarding access to the structure, which were completely discordant and without legal foundation and seriously discriminatory compared to other categories of workers who access and work in presence in the same places.

In the letter of the Sect. AIISF of Messina also remembered that the Sicily Region had included, among the category of healthcare workers, in the anti SARS-CoV-2 / COVID-19 vaccination plan, also the scientific informants of the drug and the parapharmaceutical. And it is therefore known that the ISFs of the province of Messina have already undergone the anti SARS-CoV-2 / COVID-19 vaccination and all have already completed the vaccination cycle as can be easily demonstrated by the documentation, including the so-called green pass.

Finally, it was recalled that the Health Department of the Region (Prot. No. 35008 of 07/29/2021) had clearly issued rules in order to ensure the proper performance of the professional activity carried out by the ISFs, giving them suitable dissemination.

Despite this, with an act of incomprehensible power, the Managers of the health structures mentioned above have slowed down the work activity of the ISFs and, consequently, limited scientific information (essential) for all health workers

The communication to the Health Authorities asked for the possibility of accessing the health facilities upon presentation of the green pass, thereby protecting an illegitimately mistreated category of workers (that of the ISF) who have always worked in the health sector and are able to implement all the necessary measures to contain the risk of contagion from Covid 19.

Furthermore, aligning the conduct of local hospitals with the will of the national legislator who, with the enactment of the DECREE-LAW of 21 September 2021, n. 127 has decisively clarified and consolidated the principle of guaranteeing the safe performance of work, both public and private.

On 27 October the communication to the AIISF Sez. Messina that the access of informants is allowed, upon presentation of the green pass, in a suitable place.

Related news: Legislative Decree 21 September 2021 n. 127

Redazione Fedaiisf

Promote the cohesion and union of all members to allow a univocal and homogeneous vision of the professional problems inherent in the activity of pharmaceutical sales reps.

Articoli correlati

Back to top button
Fedaiisf Federazione delle Associazioni Italiane degli Informatori Scientifici del Farmaco e del Parafarmaco